EUROGIN homepage       Saturday, November 25, 2017
 

Abstract Guidelines

 

Abstract submission is closed now. The deadline expired on June 28.


Abstracts must be submitted before June 28, 2013.


An abstract is considered to be received only if the author has received a formal acknowledgement of receipt from EUROGIN.

When submitting an abstract, please indicate if the abstract is intended for:
- oral presentation
- poster presentation
- no preference

General Conditions for Submission of Abstracts

  • Submission of an abstract implies the commitment that the presenting author registers for the Eurogin 2013 congress and that financial resources to attend are available.
  • Authors are requested to register within 10 days after having received their provisional notification of acceptance. Abstracts of authors not registered by July 19, 2013 will not be taken into consideration for the final program. For special cases like group registrations, please contact the EUROGIN secretariat at This e-mail address is being protected from spambots. You need JavaScript enabled to view it
  • Abstracts must be submitted and presented in ENGLISH.
  • Abstracts should be prepared as a WORD document in accordance with the editing instructions below, and sent by email to the EUROGIN organizing committee at the following address:

    This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Abstracts that do not comply with the editing instructions will not be considered.

  • For Free Communications or Poster sessions, only ONE abstract can be submitted per person (presenter).
  • Original scientific material is welcome and preference is given to recent findings not published yet at the date of the congress.
  • Abstracts will be peer reviewed and classified by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation.
  • The final decision of the Scientific Committee will be announced before July 19, 2013.
  • Authors agree that their abstract will be published in an Abstract Book which will be provided to all registered participants of the congress.
  • All accepted abstract authors will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract.
  • Most accepted abstracts will be allocated for poster presentation. Detailed technical instructions will be made available to the authors in due time.
  • All accepted abstracts will be published in the final abstract book of the conference.


Abstract Editing Instructions

  • Format: WORD file.
    • Maximum number of characters: 2,200, not counting spaces, but including title and accreditations.
    • Use Arial font size 11
    • The title must be written in UPPER CASE (capitals) and bold; (keep it brief, clearly indicating the nature of the investigation. It should not exceed 2 lines).
    • Please avoid complex mathematical formulae.
    • Abstracts should be structured in three sections, clearly mentioned as such: objectives – methods - conclusions.
  • Authors should be listed by their LAST NAME (family name) followed by initials of the first name only (do not include full first names). ONE author must be identified as PRESENTER by underlining of his name.
  • Give professional address for all authors: name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. If different affiliations, please use numbers.
  • Do not indent spaces on the first line of each paragraph. Abstracts should be typed single spaced, with no space between paragraphs. Use international standards for scientific articles.
  • Only standard abbreviations may be used without definition. Data must be given in units widely used in literature.
  • Only essential references should be included and put in brackets at the end of the abstract: numbers in the text may refer to them.
  • Drugs must be identified by their generic names.


Abstract Topics

For review purposes, abstracts are classified according to the following list. Select only 1 topic that best characterizes your abstract:

  1. Viral and molecular biology
  2. Epidemiology and natural history
  3. Pathogenesis
  4. Immunology
  5. HPV prophylactic vaccines: clinical aspects
  6. HPV prophylactic vaccines: basic science
  7. HPV therapeutic vaccines
  8. HPV testing
  9. Genotyping
  10. Molecular markers
  11. Screening methods
  12. Liquid based cytology
  13. Automation in cytology
  14. New technologies
  15. Diagnostic procedures
  16. Colposcopy
  17. Cervical neoplasia
  18. Vaginal neoplasia
  19. Vulvar diseases and neoplasia
  20. Anal neoplasia
  21. Oral HPV infection
  22. HPV and oropharynx / Head and neck cancer
  23. HPV and associated skin diseases
  24. HPV and other neoplasia
  25. Genital warts
  26. Sexually transmitted diseases and HIV infection
  27. Conventional therapies
  28. New treatments - Immunotherapy
  29. Economics and modelling
  30. Advocacy, acceptability and psychology
  31. Health education
  32. Low resource settings